-
Cell-Cycle Arrest as Translational Evidence
2026-08-25
DNA-content profiling can turn a qualitative growth phenotype into a mechanistically interpretable translational endpoint. This article examines how PI-based flow cytometry, anchored by the Cell Cycle Assay Kit (Catalog No. K2263), can clarify therapeutic response in ALK-positive anaplastic large cell lymphoma and other cancer models.
-
Cabazitaxel (XRP6258): Practical Workflow Guide
2026-08-24
Cabazitaxel (XRP6258) is a semi-synthetic taxane derivative for antiproliferative studies involving microtubule dynamics disruption, including P-glycoprotein-expressing and taxane-resistant cancer models. It is suitable for DMSO- or ethanol-based workflows but is insoluble in water, and prepared solutions should be used promptly rather than stored long term.
-
Entecavir: Mechanism, Safety & Assay Design
2026-08-24
Entecavir and BMS200475 suppress HBV replication through selective polymerase inhibition. This article connects mechanism, resistance biology, and a rare thrombocytopenia case to practical assay design and translational safety monitoring.
-
Milk-Derived EV Uptake in Intestinal Stem Cell Models
2026-08-23
This study establishes physiologically relevant porcine intestinal stem cell models to resolve how milk-derived extracellular vesicles are internalized across epithelial surfaces. Its findings connect organoid polarity and intestinal region with vesicle uptake, while showing that endocytosis inhibitors suppress internalization and that vesicles alter stemness- and differentiation-related gene expression in colon-derived models.
-
Valemetostat: From EZH2 Potency to Assay Design
2026-08-22
Valemetostat (DS-3201) is examined here through a genotype-aware framework that connects EZH2 biochemistry, PRC2 biology, and lymphoma assay design. The article distinguishes clinical response signals from mechanistic evidence and outlines practical parameters for rigorous epigenetic cancer research.
-
GPR107 Deficiency in Diabetic Nephropathy
2026-08-22
Xu et al. identify GPR107 as a regulator of AT1R endocytosis in podocytes, linking defective receptor trafficking to collagen IV accumulation and diabetic nephropathy progression. The study provides a mechanistic framework for examining angiotensin II signaling pathway activity, extracellular-matrix turnover, and receptor trafficking in renal disease models.
-
DiscoveryProbe Natural Product Library Plus: HTS to Insight
2026-08-21
Discover how the DiscoveryProbe Natural Product Library Plus can connect phenotypic screening with biochemical target validation. Using CpAdhE research as a case study, this article presents a rigorous path from natural-product hits to mechanism-aware leads.
-
FITC Goat Anti-Rabbit IgG (H+L) Workflow Guide
2026-08-20
Build sensitive immunofluorescence, flow cytometry, and fluorescent tissue-staining workflows around a fluorescein-conjugated secondary antibody that recognizes rabbit IgG. This guide translates intestinal barrier and ERK-pathway findings into practical assay controls, optimization steps, and troubleshooting decisions without overstating what the reference study demonstrated.
-
ASCH Proteins and N4-Acetylcytidine Processing
2026-08-20
Meng et al. define how the bacterial ASCH protein EcYqfB converts free N4-acetylcytidine into cytidine while showing that it does not remove ac4C from RNA. Structural comparisons with mouse EOLA1 and the human TRIP4-ASCH domain clarify how related proteins can have different substrate preferences, informing RNA modification and nucleotide-processing assays.
-
Z-WEHD-FMK in Caspase-1 Pyroptosis Studies
2026-08-19
Z-WEHD-FMK provides a cell-permeable, irreversible way to test inflammatory caspase dependence in pyroptosis, cancer-cell signaling, and pathogen-inclusion biology. This guide connects the HOXC8–caspase-1 lung cancer findings with practical dosing, controls, readouts, and troubleshooting strategies.
-
Propidium Iodide in Immune Cell Fate Assays
2026-08-19
Propidium iodide turns membrane damage and DNA content into actionable fluorescence readouts for viability, apoptosis, and cell-cycle experiments. In placenta–immune cell models, it complements molecular and metabolic assays by revealing whether altered T-cell behavior reflects survival, membrane failure, or cell-cycle redistribution.
-
Cell Cycle Assay Kit for Cancer Cell-Cycle Studies
2026-08-18
Use the Cell Cycle Assay Kit (K2263) to distinguish DNA-content shifts from apoptotic loss in drug-treated and genetically perturbed cells. This practical guide connects PI/RNase flow cytometry with panobinostat research in MLL-rearranged leukemia while emphasizing controls, gating, and troubleshooting.
-
Annexin V-PE Reagent: Reliable Apoptosis Assays
2026-08-18
Learn how Annexin V-PE Reagent, SKU K2280, supports practical phosphatidylserine externalization detection in flow cytometry and fluorescence microscopy. This scenario-driven guide covers assay design, compatibility, staining parameters, interpretation, and evidence-based product selection without overstating performance beyond the available product data.
-
Kanamycin Sulfate: Applied Research Workflows
2026-08-17
Kanamycin Sulfate provides a practical, water-based selection strategy for plasmid maintenance, bacterial growth assays, and antibiotic resistance research. This guide connects reliable reagent handling with the toxin-focused, microbiota-aware experimental logic highlighted in recent Clostridioides difficile research.
-
Caspase-4 Colorimetric Assay Kit Workflow
2026-08-17
Turn inflammatory and pyroptotic signaling into a quantitative LEVD-dependent readout with a practical, plate-based workflow. The assay also provides a useful extension for organelle-targeted cancer studies, where caspase-4 activity can help test whether ER stress is accompanied by an inflammatory cell-death response.